- Source type
- Study
- Access type
- Publisher
- Publisher
- JAMA
- Date
- 2008
- Added
- 2026-07-07
- Updated
- 2026-07-07
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
88
Peer-reviewed research publisher
- Publisher type
- Peer-reviewed journal
- Bias profile
- Moderate
This source is strongest for clinical outcomes and mechanism and weaker for regulatory status and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 65/100
- Context Source
- Clinical outcomes
- 92/100
- Primary Anchor
- Mechanism
- 90/100
- Primary Anchor
- Safety
- 86/100
- Strong Support
- Consumer context
- 72/100
- Context Source
- Trial discovery
- 65/100
- Context Source
Best used for
- Primary studies
- Systematic reviews
- Mechanistic research
Weak for
- Regulatory status
- Universal consumer recommendations
Used in Viral Vitalism
Microplastics, BPA, and Phthalates: Endocrine Panic or Real Exposure Signal?
Roles: Primary source
Show section-level references
- Article source list
- The plastic exposure signal is real
- Detection is not the same as personal disease certainty
- BPA and phthalates have a clearer endocrine lane than generic plastic panic
- Fertility, pregnancy, and development are the highest-sensitivity lanes
- The cardiovascular microplastics signal is important, but early
- Practical exposure reduction should be low-regret, not purity panic
- VV verdict
- Are microplastics really found in human bodies?
- Do plastics lower testosterone?
- Is heating food in plastic uniquely bad?
- Do microplastics cause heart disease?
- What swaps are worth making first?
Related studies
Related sources
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations
Retrospective EHR analysis associating semaglutide with lower incident and recurrent cannabis use disorder diagnosis.
- Trust score
- 88
- Publisher
- Molecular Psychiatry
- Access
- Publisher
- Usage
- 4 connections
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Large retrospective EHR cohort associating semaglutide with lower AUD incidence and recurrence.
- Trust score
- 88
- Publisher
- Nature Communications
- Access
- Publisher
- Usage
- 5 connections
Endocrine-disrupting chemicals: Endocrine Society scientific statement
Scientific-statement source for endocrine-disrupting chemical context, including why hazard, exposure, dose, timing, and outcome should be separated.
- Trust score
- 88
- Publisher
- Endocrine Reviews
- Access
- Publisher
- Usage
- 13 connections
Erythritol and cardiovascular event risk
Core erythritol source linking circulating erythritol with cardiovascular events and mechanistic thrombosis signals, with causality limits.
- Trust score
- 88
- Publisher
- Nature Medicine
- Access
- Publisher
- Usage
- 5 connections
GLP-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes
Large cohort study comparing GLP-1RA initiators with SGLT-2 inhibitor initiators for SUD-related outcomes.
- Trust score
- 88
- Publisher
- BMJ
- Access
- Publisher
- Usage
- 7 connections
Microplastics and nanoplastics in atheromas and cardiovascular events
Human observational source linking plastic particles detected in carotid plaque with later cardiovascular events, without proving individual causality.
- Trust score
- 88
- Publisher
- New England Journal of Medicine
- Access
- Publisher
- Usage
- 13 connections